Kala Pharmaceuticals Inc (KALA) support and resistance · $54.3M cap
Kala Pharmaceuticals Inc (KALA) is a biotechnology company listed on NASDAQ.
This page maps Kala Pharmaceuticals Inc (KALA) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported KALA revenue for 2025-12-31 was $0. Net income was -$27.0M. KALA currently screens at market cap $54.3M.
KALA currently screens at market cap $54.3M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new KALA 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the KALA quote page for the session range and the stock page for the full model.
Not investment advice.